FDA vaccine adviser Dr. James Hildreth told Granthshala’s Dawn: “It’s conceivable that by Halloween, we could see shots going into arms, but it’s going to take weeks for that process to do its job.” ” Lemon Monday.
The process is taking place as the second-highest number of new cases were reported in children in the past week, and cases in that group continue to rise sharply, according to data from the American Academy of Pediatrics published on Monday.
In Pittsburgh, UPMC Children’s Hospital officials said they are seeing a “historic” number of children in the emergency department. The hospital said in a social media post that a tent was set up outside the emergency room on Friday to help accommodate more patients.
Currently, the youngest Americans eligible for vaccination are 12 years old, and teen vaccination rates are still approaching the halfway point, according to a Granthshala analysis of CDC data.
Trials are currently underway for younger children, and Pfizer/BioNTech announced in a news release Monday that a Phase 2 trial of 3 showed that their two-dose vaccine was safe for children ages 5 to 11. produced a “strong” antibody response.
Dr Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, said expanding vaccine access will be critical to protecting children and ending the virus’ grip on America for all.
“Ultimately, if we are serious about stopping this pandemic in the United States, we need to vaccinate 85-90% of the US population,” Hotez said. “That means all adults, all teenagers and a large number of young children.”
But there’s still a bigger challenge: getting the dose into the arms of children, says Granthshala medical analyst Dr. Jonathan Rainer said.
While some parents are eager to vaccinate their children, others are more hesitant.
“While this seems like a guarantee that parents will pass this vaccine to their children, we have to do a better job educating a very diverse group of Americans that this vaccine is safe and effective,” he said.
But when health care professionals talk with families about the decision, Granthshala medical analyst Dr. Lena Wayne said she thinks it’s OK that some parents aren’t ready.
“I understand some of them don’t want to go first,” Wayne said. “There’s another section of parents who are really curious, who will do anything to get their kids vaccinated. Let them go first.”
school policy changes
As the vaccine process is underway, schools are navigating how to manage the safety of students on campus.
New quarantine protocols for students and faculty at Miami-Dade County Public Schools went into effect Monday, requiring staff members and high school students to be exposed to COVID-19 from 10 days to 5 days , as long as they have a negative test and are symptom free.
Miami-Dade Superintendent Alberto Carvalho said masks are still required for all teachers and students, but indicated that it is something they will continue to see as the years go by.
He said, “These are the metrics that we are rolling out to our task force…
New York City officials also reduced quarantine times for exposed students, allowing masked students in a classroom to undergo quarantine if there was risk within the classroom and placing them three feet apart.
New York City Mayor Bill de Blasio said that starting next week, schools will increase student testing to once a week.
Boosters can expand to more populations, says Fauci
Booster vaccine doses are another consideration to increase protection against the virus and while the population under consideration for authorization to receive them is limited, National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci said the group could be expanding.
FDA vaccine advisors voted Friday to recommend emergency use authorization of booster doses of Pfizer’s vaccine for people age 65 and older and those at high risk of severe COVID-19. The FDA has yet to act on that recommendation.
But Fauci told Granthshala’s Wolf Blitzer that the FDA will follow the data coming in from the US and Israel in real time and adjust any authorizations accordingly.
Fauci said, “The lack of protection against serious disease, especially in younger groups, will prompt the FDA to look into that and see if they want to expand the recommendation to go much younger than 65.” “
If that data comes in, “then I think it’s likely, as we go on in the coming weeks, we’ll see more and more expansion of the booster recommendation for those individuals,” Fauci said.
Those who received either Moderna or the one-dose Johnson & Johnson vaccine for their initial vaccine, Fauci said, “have not been forgotten.”
“The data on boosters in those individuals will come to the FDA, I would imagine in a couple to three weeks,” he said. “They will test it the same way they did before, and hopefully they will find a recommendation that will provide equity between people who have different products in their vaccination regimen.”
Granthshala’s Jen Christensen, Jacqueline Howard, Amanda Seeley, Lauren Mascarenhas, Elizabeth Stuart, Christina Sguglia
Credit : www.cnn.com